MEI Pharma, Inc. (MEIP)
MEIP moved a median of +0.07% 30 minutes after news, and -0.30% by the close. How MEIP actually reacts to news — the realized, point-in-time move the market made, measured across 152 labeled events over the last three years with zero look-ahead.
MEIP’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 24% | 123 |
| 30-min | +0.07% | 51% | 144 |
| 60-min | -0.42% | 37% | 148 |
| to close | -0.30% | 45% | 148 |
| Middle 50% of MEIP reactions | -1.44% to +1.12% |
|---|---|
| Median reaction (30-min) | +0.07% |
| Measured reactions | 152 |
Half of all MEI Pharma, Inc. news events land between -1.44% and +1.12% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when MEIP moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to MEIP's baseline. Nothing else.
Recent MEIP events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form 8-K Lite Strategy, Inc. For: Sep 10 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K MEI Pharma, Inc. For: Sep 10 | SEC filing · Form 8-K | SEC EDGAR | -1.04% | +6.23% | |
| MEI Pharma, Inc. Rebrands as Lite Strategy, Inc., Adopts New NASDAQ Ticker ‘LITS’ | Press release | Business Wire | -1.04% | +6.23% | |
| Form EFFECT MEI Pharma, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +1.70% | -7.12% | |
| Form 8-K MEI Pharma, Inc. For: Sep 03 | SEC filing · Form 8-K | SEC EDGAR | -0.58% | -2.54% | |
| Form S-3/A MEI Pharma, Inc. | SEC filing · Form S-3 | SEC EDGAR | -1.51% | -2.46% | |
| Form 8-K MEI Pharma, Inc. For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | -0.79% | +0.99% | |
| Form S-3 MEI Pharma, Inc. | SEC filing · Form S-3 | SEC EDGAR | -0.79% | +0.99% | |
| Form 8-K MEI Pharma, Inc. For: Aug 05 | SEC filing · Form 8-K | SEC EDGAR | -0.76% | -4.72% | |
| MEI Pharma Acquires Litecoin, Launches $100M Institutional Treasury Strategy with Charlie Lee and GSR Advising | Press release | Business Wire | -0.76% | -4.72% | |
| Form 8-K MEI Pharma, Inc. For: Jul 24 | SEC filing · Form 8-K | SEC EDGAR | +2.36% | +1.38% | |
| Form 8-K MEI Pharma, Inc. For: Jul 17 | SEC filing · Form 8-K | SEC EDGAR | -5.20% | +1.81% | |
| MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange | Press release | Business Wire | -5.20% | +1.81% | |
| MEI Pharma Announces $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange | Press release | Business Wire | -16.09% | -33.85% | |
| Form 10-Q MEI Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | +5.71% | |
| Form 8-K MEI Pharma, Inc. For: May 13 | SEC filing · Form 8-K | SEC EDGAR | — | +5.71% | |
| MEI Pharma Reports Third Quarter Fiscal Year 2025 Cash Position | Press release | Business Wire | — | +5.71% | |
| Form 8-K MEI Pharma, Inc. For: Mar 03 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.41% | |
| Form 10-Q MEI Pharma, Inc. For: Dec 31 | SEC filing · Form 10-Q | SEC EDGAR | +2.70% | +5.02% | |
| Form 8-K MEI Pharma, Inc. For: Feb 12 | SEC filing · Form 8-K | SEC EDGAR | +2.70% | +5.02% | |
| MEI Pharma Reports Second Quarter Fiscal Year 2025 Cash Position | Press release | Business Wire | +2.70% | +5.02% | |
| Form 8-K MEI Pharma, Inc. For: Jan 30 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form ARS MEI Pharma, Inc. For: Jun 30 | SEC filing · Form ARS | SEC EDGAR | +1.63% | -4.07% | |
| Form DEF 14A MEI Pharma, Inc. For: Dec 20 | SEC filing · Form DEF | SEC EDGAR | +1.63% | -4.07% | |
| Form DEFA14A MEI Pharma, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +1.63% | -4.07% | |
| Form 8-K MEI Pharma, Inc. For: Nov 22 | SEC filing · Form 8-K | SEC EDGAR | — | +1.07% | |
| Form 8-K MEI Pharma, Inc. For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | -1.01% | -2.01% | |
| Form 10-Q MEI Pharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.32% | -1.94% | |
| MEI Pharma Reports First Quarter Fiscal Year 2025 Cash Position | Press release | Business Wire | -0.32% | -1.94% | |
| Form 8-K MEI Pharma, Inc. For: Oct 22 | SEC filing · Form 8-K | SEC EDGAR | +0.17% | +4.58% | |
| Form 10-K MEI Pharma, Inc. For: Jun 30 | SEC filing · Form 10-K | SEC EDGAR | -5.23% | -8.31% | |
| Form 8-K MEI Pharma, Inc. For: Sep 19 | SEC filing · Form 8-K | SEC EDGAR | -5.23% | -8.31% | |
| MEI Pharma Reports Fiscal Year End 2024 Cash Position | Press release | Business Wire | -5.23% | -8.31% | |
| MEI Pharma Engages Oppenheimer & Co. Inc. to Assist in Evaluating Strategic Alternatives | Press release | Business Wire | +0.00% | -1.43% | |
| Form 8-K MEI Pharma, Inc. For: Jul 31 | SEC filing · Form 8-K | SEC EDGAR | -0.60% | +5.17% | |
| Form 8-K MEI Pharma, Inc. For: Jul 30 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +11.08% | |
| Form 8-K MEI Pharma, Inc. For: Jul 21 | SEC filing · Form 8-K | SEC EDGAR | -1.13% | +2.82% | |
| MEI Pharma to Consider Strategic Alternatives | Press release | Business Wire | +5.59% | +7.76% | |
| Form 8-K MEI Pharma, Inc. For: Jun 18 | SEC filing · Form 8-K | SEC EDGAR | +2.09% | +1.06% | |
| Form 8-K MEI Pharma, Inc. For: May 21 | SEC filing · Form 8-K | SEC EDGAR | — | -0.31% | |
| Form 10-Q MEI Pharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -1.63% | |
| Form 8-K MEI Pharma, Inc. For: May 09 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -1.63% | |
| MEI Pharma Reports Third Quarter Fiscal Year 2024 Results and Operational Highlights | Press release | Business Wire | +0.00% | -1.63% | |
| MEI Pharma Board of Directors Aligns on Strategy to Advance Voruciclib and ME-344 | Press release | Business Wire | +0.00% | -3.71% | |
| MEI Pharma Reports Initial Data from Clinical Study Evaluating ME-344 in Combination with Bevacizumab (Avastin®) in Relapsed Metastatic Colorectal Cancer Patients | Press release | Business Wire | +0.00% | -3.71% | |
| MEI Pharma to Present at the Stifel 2024 Virtual Targeted Oncology Forum | Press release | Business Wire | +0.53% | -1.05% | |
| MEI Pharma Reports Update from Clinical Study Evaluating Oral CDK9 Inhibitor Voruciclib in Combination with Venetoclax in Patients with Relapsed and Refractory Acute Myeloid Leukemia | Press release | Business Wire | -6.53% | +0.78% | |
| Form EFFECT MEI Pharma, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | +0.48% | |
| Form 8-K MEI Pharma, Inc. For: Feb 20 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -7.67% | |
| Form S-3 MEI Pharma, Inc. | SEC filing · Form S-3 | SEC EDGAR | +0.00% | +1.34% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the MEIP section they belong to.
Where else MEIP is measured.
MEIP earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PROMETIC LIFE SCIENCE (PFSCF) | 153 | 0.00% | 34% |
| Aptose Biosciences, Inc. - Common Shares (APTO) | 152 | -1.33% | 35% |
| Milestone Scientific, Inc. (MLSS) | 152 | 0.00% | 50% |
| ProQR Therapeutics N.V. - Ordinary Shares (PRQR) | 152 | -0.42% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is MEI Pharma, Inc.'s median reaction calculated?
Every labeled MEIP news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 152 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 51% of MEIP's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does MEIP's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.